批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
| 审批日期 | 提交号 | 审批结论 | 提交分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2014/09/05 |
ORIG-1(原始申请) |
Approval |
Type 5 - New Formulation or New Manufacturer |
STANDARD
|
|
|
>>>补充申请<<<
| 审批日期 | 提交号 | 审批结论 | 补充类别或审批类型 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2024/01/19 |
SUPPL-29(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2021/03/10 |
SUPPL-27(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2017/11/06 |
SUPPL-13(补充) |
Approval |
Efficacy-New Indication |
STANDARD
|
|
|
| 2016/12/19 |
SUPPL-11(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2016/11/09 |
SUPPL-10(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2016/05/02 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2015/08/27 |
SUPPL-7(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2015/08/04 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2015/07/21 |
SUPPL-4(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2015/07/14 |
SUPPL-5(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2015/05/22 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2015/05/18 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2014/11/15 |
SUPPL-1(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
>>>活性成分:FERRIC CITRATE; 剂型/给药途径:TABLET;ORAL; 规格:EQ 210MG IRON; 治疗等效代码:AB<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 205874 |
001 |
NDA |
AURYXIA |
FERRIC CITRATE |
TABLET;ORAL |
EQ 210MG IRON |
Prescription |
Yes |
Yes |
AB |
2014/09/05
|
KERYX BIOPHARMS |
| 212563 |
001 |
ANDA |
FERRIC CITRATE |
FERRIC CITRATE |
TABLET;ORAL |
EQ 210MG IRON |
Prescription |
No |
No |
AB |
2026/03/11
|
TEVA PHARMS USA |